Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.9699
Delayed Data
As of Aug 26
 -0.0001 / -0.01%
Today’s Change
0.82
Today|||52-Week Range
1.57
-23.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues15.2M3.6M1.2M193.0K
 
 
 
 
 
Depreciation And Amortization97.0K6.0K5.0K2.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses6.6M9.7M8.4M7.3M
 
 
 
 
 
Research And Development4.4M3.9M6.0M5.6M
 
 
 
 
 
Total Operating Expenses6.7M9.7M8.4M7.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income8.5M-6.1M-7.2M-7.1M
 
 
 
 
 
Extraordinary Charge----0.00-996.0K
 
 
Interest Expense On Debt533.0K425.0K386.0K468.0K
 
 
 
 
 
Other Expenses-22.0K-44.0K-9.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income7.9M-6.6M-7.6M-8.6M
 
 
 
 
 
Income Taxes0.000.00-100.0K0.00
 
 
Net Income7.9M-6.6M-7.7M-8.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.8M58.1M58.2M66.9M
 
 
 
 
 
Shares To Calculate EPS Diluted57.0M58.1M58.2M66.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.14-$0.11-$0.13-$0.13
 
 
 
 
 
EPS Diluted$0.14-$0.11-$0.13-$0.13